{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:37:21Z","timestamp":1769557041199,"version":"3.49.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.molimm.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T05:14:12Z","timestamp":1663478052000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Inflammasome activation and assembly in Huntington\u2019s disease"],"prefix":"10.1016","volume":"151","author":[{"given":"Tiago","family":"de Oliveira Furlam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isadora Gon\u00e7alves","family":"Roque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelin Wasner","family":"Machado da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Parenti","family":"Vianna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Aparecida","family":"Costa Valad\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Guatimosim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio L\u00facio","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline Silva","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2022.09.002_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","article-title":"Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line","volume":"69","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurosci. Res"},{"key":"10.1016\/j.molimm.2022.09.002_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression","volume":"11","author":"Andreassen","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molimm.2022.09.002_bib3","article-title":"Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy","author":"de Ara\u00fajo","year":"2021","journal-title":"Cell Mol. Neurobiol. 10. 1007\/s10571-020-01027-6. Adv. Online Publ."},{"key":"10.1016\/j.molimm.2022.09.002_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/arclin\/acq038","article-title":"Episodic memory in dementia: Characteristics of new learning that differentiate Alzheimer's, Huntington's, and Parkinson's diseases","volume":"25","author":"Aretouli","year":"2010","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.molimm.2022.09.002_bib5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2022.09.002_bib6","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.molimm.2022.09.002_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuropharm.2015.09.019","article-title":"Purinergic mechanisms in neuroinflammation: An update from molecules to behavior","volume":"104","author":"Beamer","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molimm.2022.09.002_bib8","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2022.09.002_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2826.2009.01898.x","article-title":"Huntington's disease does not appear to increase the risk of diabetes mellitus","volume":"21","author":"Boesgaard","year":"2009","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.molimm.2022.09.002_bib10","doi-asserted-by":"crossref","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","article-title":"Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease","volume":"32","author":"Bouchard","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molimm.2022.09.002_bib11","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molimm.2022.09.002_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","article-title":"Mitochondrial Dysfunction in Huntington's Disease","volume":"1049","author":"Carmo","year":"2018","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.molimm.2022.09.002_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington's disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.molimm.2022.09.002_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuro.2017.01.005","article-title":"Risk factors for the onset and progression of Huntington disease","volume":"61","author":"Chao","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.molimm.2022.09.002_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12974-022-02419-9","article-title":"A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington's disease","volume":"19","author":"Chen","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.molimm.2022.09.002_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat. Med"},{"key":"10.1016\/j.molimm.2022.09.002_bib17","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1523\/JNEUROSCI.0116-08.2008","article-title":"Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5\/RANTES) by astrocytes","volume":"28","author":"Chou","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molimm.2022.09.002_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41422-020-0295-8","article-title":"Toward targeting inflammasomes: insights into their regulation and activation","volume":"30","author":"Christgen","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.molimm.2022.09.002_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055375","article-title":"Triggering of inflammasome by aggregated \u03b1-synuclein, an inflammatory response in synucleinopathies","volume":"8","author":"Codolo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2022.09.002_bib20","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","article-title":"Akt is altered in an animal model of Huntington's disease and in patients","volume":"21","author":"Colin","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.molimm.2022.09.002_bib21","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.4103\/1673-5374.215245","article-title":"Promises and pitfalls of immune-based strategies for Huntington's disease","volume":"12","author":"Colpo","year":"2017","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.molimm.2022.09.002_bib22","first-page":"936","article-title":"Immunomodulatory Strategies for Huntington's Disease Treatment","volume":"16","author":"Colpo","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.molimm.2022.09.002_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuroscience.2016.03.031","article-title":"Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin","volume":"325","author":"Connolly","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.molimm.2022.09.002_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/brain\/awz363","article-title":"Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease","volume":"143","author":"Crapser","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.molimm.2022.09.002_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.02.102","article-title":"DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6\/2) reveals neuroinflammation and insulin associations","volume":"1088","author":"Crocker","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.molimm.2022.09.002_bib26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib27","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.molimm.2022.09.002_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11481-017-9754-5","article-title":"The Ketone Body \u03b2-Hydroxybutyrate Does Not Inhibit Synuclein Mediated Inflammasome Activation in Microglia","volume":"12","author":"Deora","year":"2017","journal-title":"J. Neuroimmune Pharm."},{"key":"10.1016\/j.molimm.2022.09.002_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington's disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11302-020-09735-w","article-title":"P2X7 is a cytotoxic receptor maybe not: implications for cancer","volume":"17","author":"Di Virgilio","year":"2020","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.molimm.2022.09.002_bib31","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molimm.2022.09.002_bib32","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1084\/jem.20160776","article-title":"Potential biomarkers to follow the progression and treatment response of Huntington's disease","volume":"213","author":"Disatnik","year":"2016","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2022.09.002_bib33","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djouss\u00e9","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2022.09.002_bib34","first-page":"599","article-title":"Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review","volume":"41","author":"Dong","year":"2018","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.molimm.2022.09.002_bib35","first-page":"1520","article-title":"Natural history of Huntington disease","volume":"70","author":"Dorsey","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib36","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY","volume":"85","author":"van Duijn","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.molimm.2022.09.002_bib37","doi-asserted-by":"crossref","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical neurology and epidemiology of the major neurodegenerative diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.molimm.2022.09.002_bib38","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","article-title":"Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records","volume":"84","author":"Evans","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.molimm.2022.09.002_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","article-title":"Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson's disease","volume":"17","author":"Fan","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.molimm.2022.09.002_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1074\/mcp.M800231-MCP200","article-title":"Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease","volume":"8","author":"Fang","year":"2009","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.molimm.2022.09.002_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","article-title":"Diabetes mellitus in Huntington disease","volume":"27","author":"Farrer","year":"1985","journal-title":"Clin. Genet"},{"key":"10.1016\/j.molimm.2022.09.002_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajpa.1330670304","article-title":"An anthropometric assessment of Huntington's disease patients and families","volume":"67","author":"Farrer","year":"1985","journal-title":"Am. J. Phys. Anthr."},{"key":"10.1016\/j.molimm.2022.09.002_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.1320210213","article-title":"Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease","volume":"21","author":"Farrer","year":"1985","journal-title":"Am. J. Med Genet"},{"key":"10.1016\/j.molimm.2022.09.002_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mds.25717","article-title":"Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk","volume":"29","author":"Fisher","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molimm.2022.09.002_bib45","first-page":"605","article-title":"The measurement of abnormal movement: methods developed for Huntington's disease","volume":"5","author":"Folstein","year":"1983","journal-title":"Neurobehav. Toxicol. Teratol."},{"key":"10.1016\/j.molimm.2022.09.002_bib46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.20150237","article-title":"NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes","volume":"214","author":"Freeman","year":"2017","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2022.09.002_bib47","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.3390\/ijms21124223","article-title":"Focus on the Role of NLRP3 Inflammasome in Diseases","volume":"21","author":"Fusco","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.molimm.2022.09.002_bib48","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.4161\/cc.7.22.7073","article-title":"SNP-guided microRNA maps (MirMaps) of 16 common human disorders identify a clinically accessible therapy reversing transcriptional aberrations of nuclear import and inflammasome pathways","volume":"7","author":"Glinsky","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.molimm.2022.09.002_bib49","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molimm.2022.09.002_bib50","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/mds.26001","article-title":"Genetic modifiers of Huntington's disease","volume":"29","author":"Gusella","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molimm.2022.09.002_bib51","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.570711","article-title":"The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease","volume":"11","author":"Hanslik","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mds.27874","article-title":"Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease","volume":"35","author":"Haque","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molimm.2022.09.002_bib54","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.4049\/jimmunol.1301490","article-title":"Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation","volume":"191","author":"Heid","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib55","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2022.09.002_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib57","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molimm.2022.09.002_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.643254","article-title":"Neurodegenerative Disease and the NLRP3 Inflammasome","volume":"12","author":"Holbrook","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.molimm.2022.09.002_bib59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nri2690","article-title":"Intracellular DNA recognition","volume":"10","author":"Hornung","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib60","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-\u03baB-dependent inflammation in Huntington's disease","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.molimm.2022.09.002_bib61","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molimm.2022.09.002_bib62","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/cdd.2015.16","article-title":"Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation","volume":"22","author":"Kaushal","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molimm.2022.09.002_bib63","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.molimm.2022.09.002_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/intimm\/dxx018","article-title":"Mechanisms governing inflammasome activation, assembly and pyroptosis induction","volume":"29","author":"Kesavardhana","year":"2017","journal-title":"Int Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib65","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.3390\/ijms22168363","article-title":"New Avenues for the Treatment of Huntington's Disease","volume":"22","author":"Kim","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.molimm.2022.09.002_bib66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/WCO.0000000000000116","article-title":"An update on Huntington's disease: from the gene to the clinic","volume":"27","author":"Kim","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib67","doi-asserted-by":"crossref","unstructured":"Kraft, A.D., Kaltenbach, L.S., Lo, D.C., Harry, G.J., 2012, Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons. Neurobiol Aging. 33, 621.e17\u2013621.e6.21E33. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.02.015.","DOI":"10.1016\/j.neurobiolaging.2011.02.015"},{"key":"10.1016\/j.molimm.2022.09.002_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","article-title":"CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches","volume":"153B","author":"Langbehn","year":"2010","journal-title":"Am. J. Med Genet B Neuropsychiatr. Genet"},{"key":"10.1016\/j.molimm.2022.09.002_bib69","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib70","first-page":"1173","article-title":"Oral treatment with herbal formula B307 alleviates cardiac failure in aging R6\/2 mice with Huntington's disease via suppressing oxidative stress, inflammation, and apoptosis","volume":"10","author":"Lin","year":"2015","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.molimm.2022.09.002_bib71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2022.09.002_bib72","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20428","article-title":"Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia","volume":"57","author":"Markianos","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib74","unstructured":"Menalled, L.B., Kudwa, A.E., Miller, S., Fitzpatrick, J., Watson-Johnson, J., Keating, N., et al., 2012, Comprehensive behavioral and molecular characterization of a new Knock- in mouse model of Huntington's disease: ZQ175. PLoS One 72, 83\u201397. https:\/\/doi.org\/10. 1371\/journal.pone.0049838."},{"key":"10.1016\/j.molimm.2022.09.002_bib75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013006875","article-title":"Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases","volume":"24","author":"Morales","year":"2014","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.molimm.2022.09.002_bib76","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-0004.2010.01538.x","article-title":"Uptake of Huntington disease predictive testing in a complete population","volume":"80","author":"Morrison","year":"2011","journal-title":"Clin. Genet"},{"key":"10.1016\/j.molimm.2022.09.002_bib77","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","article-title":"Factors associated with slow progression in Huntington's disease","volume":"48","author":"Myers","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib78","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus","volume":"50","author":"Myers","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib79","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.567430","article-title":"P2X7 receptor upregulation in Huntington\u2019s Disease Brains","volume":"13","author":"Olla","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.molimm.2022.09.002_bib81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease","volume":"399","author":"Ona","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2022.09.002_bib82","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41420-020-00293-z","article-title":"Pyroptotic cell death in the R6\/2 mouse model of Huntington's disease: new insight on the inflammasome","volume":"6","author":"Paldino","year":"2020","journal-title":"Cell Death Disco"},{"key":"10.1016\/j.molimm.2022.09.002_bib83","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/cells9102286","article-title":"Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6\/2 Mouse Model of Huntington's Disease","volume":"9","author":"Paldino","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.molimm.2022.09.002_bib84","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2022.09.002_bib85","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/mds.22953","article-title":"Cognitive and functional decline in Huntington's disease: dementia criteria revisited","volume":"25","author":"Peavy","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molimm.2022.09.002_bib86","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington's disease: an in vivo PET study","volume":"131","author":"Politis","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.molimm.2022.09.002_bib87","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.molimm.2022.09.002_bib88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molimm.2022.09.002_bib89","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/00048679109077743","article-title":"The fertility of HD-affected individuals in Tasmania","volume":"25","author":"Pridmore","year":"1991","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.molimm.2022.09.002_bib90","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molimm.2022.09.002_bib91","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/med.21784","article-title":"Microglia-derived galectin-3 in neuroinflammation; a bittersweet ligand?","volume":"41","author":"Rahimian","year":"2021","journal-title":"Med Res Rev."},{"issue":"Suppl 2","key":"10.1016\/j.molimm.2022.09.002_bib92","doi-asserted-by":"crossref","DOI":"10.1590\/1516-4446-2013-1157","article-title":"Animal models of neurodegenerative diseases","volume":"35","author":"Ribeiro","year":"2013","journal-title":"Rev. Bras. Psiquiatr"},{"key":"10.1016\/j.molimm.2022.09.002_bib93","doi-asserted-by":"crossref","first-page":"8653132","DOI":"10.1155\/2016\/8653132","article-title":"Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies","volume":"2016","author":"Rocha","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.molimm.2022.09.002_bib94","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000984","article-title":"Microglia activation in basal ganglia is a late event in huntington disease pathophysiology","volume":"8","author":"Rocha","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.molimm.2022.09.002_bib95","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2022.09.002_bib96","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib97","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","article-title":"Degeneration of the cerebellum in Huntington's disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process","volume":"23","author":"R\u00fcb","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.molimm.2022.09.002_bib98","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/bpa.12115","article-title":"Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem","volume":"24","author":"R\u00fcb","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.molimm.2022.09.002_bib99","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"S\u00e1nchez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2022.09.002_bib100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","article-title":"The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease","volume":"11","author":"Saresella","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"No","key":"10.1016\/j.molimm.2022.09.002_bib102","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1093\/hmg\/ddm213","article-title":"Polyglutamine diseases: emerging concepts in pathogenesis and therapy","volume":"2","author":"Shao","year":"2007","journal-title":"Hum. Mol. Genet. 16 Spec."},{"key":"10.1016\/j.molimm.2022.09.002_bib103","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2174\/1389450122666210224105945","article-title":"Mitochondrial dysfunction in Huntington's disease: pathogenesis and therapeutic opportunities","volume":"22","author":"Sharma","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.molimm.2022.09.002_bib104","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2022.09.002_bib105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.molimm.2022.09.002_bib106","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1038\/s41467-019-11441-0","article-title":"Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease","volume":"10","author":"Siew","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2022.09.002_bib107","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"issue":"13","key":"10.1016\/j.molimm.2022.09.002_bib108","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective Striatal Neuronal Loss in a YAC128 Mouse Model of Huntington Disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.molimm.2022.09.002_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"key":"10.1016\/j.molimm.2022.09.002_bib110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","article-title":"Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease","volume":"83","author":"Stout","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.molimm.2022.09.002_bib111","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1531-8249(200007)48:1<130::AID-ANA27>3.0.CO;2-8","article-title":"Weight loss in Huntington's disease","volume":"48","author":"Stoy","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib112","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib113","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.3390\/ijerph18105113","article-title":"Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington's Disease Using the Enroll-HD Global Platform","volume":"18","author":"Symonds","year":"2021","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.molimm.2022.09.002_bib114","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington's disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.molimm.2022.09.002_bib115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","article-title":"Imaging microglial activation in Huntington's disease","volume":"72","author":"Tai","year":"2007","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.molimm.2022.09.002_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.617036","article-title":"P2X 7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches","volume":"15","author":"Territo","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.molimm.2022.09.002_bib117","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","article-title":"Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease","volume":"24","author":"Thompson","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.molimm.2022.09.002_bib118","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0962-8924(00)01853-5","article-title":"Huntington's disease: the challenge for cell biologists","volume":"10","author":"Tobin","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.molimm.2022.09.002_bib119","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington's disease","volume":"20","author":"Trejo","year":"2004","journal-title":"Nutrition"},{"key":"10.1016\/j.molimm.2022.09.002_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116653","article-title":"Inflammatory changes in peripheral organs in the BACHD murine model of Huntington's disease","volume":"232","author":"Valad\u00e3o","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.molimm.2022.09.002_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577380","article-title":"Inflammation in Huntington's disease: A few new twists on an old tale","volume":"348","author":"Valad\u00e3o","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib122","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molimm.2022.09.002_bib123","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrn3638","article-title":"Inflammasomes in the CNS","volume":"15","author":"Walsh","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molimm.2022.09.002_bib124","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson's disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.molimm.2022.09.002_bib125","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein \u03b1-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molimm.2022.09.002_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1231","article-title":"Abnormal peripheral chemokine profile in Huntington's disease","author":"Wild","year":"2011","journal-title":"PLoS Curr."},{"key":"10.1016\/j.molimm.2022.09.002_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.657338","article-title":"Purinergic Signaling in the Pathophysiology and Treatment of Huntington\u2019s Disease","volume":"15","author":"Wiprich","year":"2021","journal-title":"Front Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.molimm.2022.09.002_bib128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"Woodman","year":"2007","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.molimm.2022.09.002_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101202","article-title":"Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases","volume":"65","author":"Wu","year":"2021","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.molimm.2022.09.002_bib130","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fimmu.2020.00724","article-title":"TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2022.09.002_bib131","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Disco"},{"key":"10.1016\/j.molimm.2022.09.002_bib132","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.4049\/jimmunol.1700352","article-title":"Cutting edge: distinct regulatory mechanisms control proinflammatory cytokines IL-18 and IL-1\u03b2","volume":"198","author":"Zhu","year":"2017","journal-title":"J. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589022004230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589022004230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:44:48Z","timestamp":1758980688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589022004230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":132,"alternative-id":["S0161589022004230"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2022.09.002","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammasome activation and assembly in Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}